Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Akihito Kojima"'
Autor:
Kensei Yamaguchi, Yung-Jue Bang, Satoru Iwasa, Naotoshi Sugimoto, Min-Hee Ryu, Daisuke Sakai, Hyun Cheol Chung, Hisato Kawakami, Hiroshi Yabusaki, Jeeyun Lee, Tatsu Shimoyama, Keun-Wook Lee, Kaku Saito, Yoshinori Kawaguchi, Takahiro Kamio, Akihito Kojima, Masahiro Sugihara, Kohei Shitara
Publikováno v:
Journal of Clinical Oncology. 41:816-825
PURPOSE To investigate efficacy and safety of trastuzumab deruxtecan (T-DXd) in human epidermal growth factor receptor 2 (HER2)–low gastric or gastroesophageal junction (GEJ) adenocarcinoma. METHODS Patients with locally advanced or metastatic HER2
Autor:
Kohei Shitara, Hisato Kawakami, Jeeyun Lee, DESTINY-Gastric Investigators, Hyun-Cheol Chung, Akihito Kojima, Daisuke Sakai, Min-Hee Ryu, Masahiro Sugihara, Kensei Yamaguchi, Hiroshi Yabusaki, Satoru Iwasa, Takahiro Kamio, Naotoshi Sugimoto, Yung-Jue Bang, Yoshinori Kawaguchi, Kaku Saito
Publikováno v:
New England Journal of Medicine. 382:2419-2430
Trastuzumab deruxtecan (DS-8201) is an antibody-drug conjugate consisting of an anti-HER2 (human epidermal growth factor receptor 2) antibody, a cleavable tetrapeptide-based linker, and a cytotoxic topoisomerase I inhibitor. The drug may have efficac
Autor:
Kohei Shitara, Yung-Jue Bang, Satoru Iwasa, Naotoshi Sugimoto, Min-Hee Ryu, Daisuke Sakai, Hyun Cheol Cheol Chung, Yasushi Omuro, Hisato Kawakami, Hiroshi Yabusaki, Yasuhiro Sakamoto, Tomohiro Nishina, Koichiro Inaki, Yusuke Kuwahara, Fumitaka Suto, Masahiro Sugihara, Kaku Saito, Akihito Kojima, Kensei Yamaguchi
Publikováno v:
Journal of Clinical Oncology. 40:322-322
322 Background: T-DXd is a HER2-targeting antibody-drug conjugate. In primary analyses of DG-01 (NCT03329690), T-DXd showed clinically meaningful improvement in objective response rate (ORR) and overall survival (OS) vs chemotherapy in the primary co
Autor:
Tomohiro Nishina, H.C. Chung, Hisato Kawakami, Naotoshi Sugimoto, Yusuke Kuwahara, K. Shitara, Kaku Saito, Min-Hee Ryu, Masahiro Sugihara, Hiroshi Yabusaki, Kensei Yamaguchi, Yasutoshi Sakamoto, F. Suto, Y.-J. Bang, Akihito Kojima, Koichiro Inaki, Yasushi Omuro, Satoru Iwasa, D. Sakai
Publikováno v:
Annals of Oncology. 32:S224
Autor:
Min-Hee Ryu, Daisuke Sakai, Masahiro Sugihara, Yung-Jue Bang, Hyun Cheol Chung, Hisato Kawakami, Hiroshi Yabusaki, Naotoshi Sugimoto, Yoshinori Kawaguchi, Kaku Saito, Satoru Iwasa, Jeeyun Lee, Takahiro Kamio, Akihito Kojima, Kensei Yamaguchi, Kohei Shitara
Publikováno v:
Journal of Clinical Oncology. 39:4048-4048
4048 Background: T-DXd is an antibody–drug conjugate comprising an anti-HER2 antibody, a cleavable tetrapeptide-based linker, and a topoisomerase I inhibitor. DESTINY-Gastric01 (DS8201-A-J202; ClinicalTrials.gov, NCT03329690) is an open-label, mult
Autor:
Y.-J. Bang, Yoshinori Kawaguchi, Kaku Saito, Hisato Kawakami, J.W. Lee, Satoru Iwasa, Akihito Kojima, K. Shitara, D. Sakai, Naotoshi Sugimoto, Takahiro Kamio, Masahiro Sugihara, H.C. Chung, Hiroshi Yabusaki, M-H. Ryu, Kensei Yamaguchi
Publikováno v:
Annals of Oncology. 31:S899-S900
Autor:
Yoshinori Kawaguchi, Kaku Saito, Akihito Kojima, D. Sakai, H.C. Chung, Kohei Shitara, Kensei Yamaguchi, Hiroshi Yabusaki, Satoru Iwasa, Y.-J. Bang, Takahiro Kamio, Hisato Kawakami, Min-Hee Ryu, Masahiro Sugihara, Naotoshi Sugimoto, J.W. Lee
Publikováno v:
Annals of Oncology. 31:235
Autor:
Yoshinori Kawaguchi, Kaku Saito, Hiroshi Yabusaki, Daisuke Sakai, Kohei Shitara, Hisato Kawakami, Jeeyun Lee, Akihito Kojima, Min-Hee Ryu, Satoru Iwasa, Masahiro Sugihara, Kensei Yamaguchi, Yung-Jue Bang, Takahiro Kamio, Hyun Cheol Chung, Naotoshi Sugimoto
Publikováno v:
Journal of Clinical Oncology. 38:4513-4513
4513 Background: T-DXd is an antibody-drug conjugate composed of an anti-HER2 antibody, cleavable tetrapeptide-based linker, and topoisomerase I inhibitor. In a phase 1 trial of T-DXd (5.4 or 6.4 mg/kg), the objective response rate (ORR) was 43.2% (1
Autor:
Akihito Kojima, Hidekazu Nishimura
Publikováno v:
JSME International Journal Series C. 41:37-45
Autor:
Hidekazu Nishimura, Akihito Kojima
Publikováno v:
Volume 1B: 16th Biennial Conference on Mechanical Vibration and Noise.
This paper proposes a design method for an active vibration isolation controller for a multi-degree-of-freedom structure with uncertainties of its base. It is demonstrated that a controller which has a desired performance can be designed even if we d